0001209191-15-047701.txt : 20150528 0001209191-15-047701.hdr.sgml : 20150528 20150528185916 ACCESSION NUMBER: 0001209191-15-047701 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150526 FILED AS OF DATE: 20150528 DATE AS OF CHANGE: 20150528 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACYCLICS INC CENTRAL INDEX KEY: 0000949699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943148201 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 BUSINESS PHONE: 408 774 0330 MAIL ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mehta Minesh CENTRAL INDEX KEY: 0001446680 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26658 FILM NUMBER: 15896799 MAIL ADDRESS: STREET 1: 995 EAST ARQUES AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-26 0 0000949699 PHARMACYCLICS INC PCYC 0001446680 Mehta Minesh C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085 1 0 0 0 Stock Option (Right to Buy) 2.30 2015-05-26 4 D 0 4000 D 2018-09-10 Common Stock 4000 0 D Stock Option (Right to Buy) 14.26 2015-05-26 4 D 0 7500 D 2021-12-15 Common Stock 7500 0 D Stock Option (Right to Buy) 28.47 2015-05-26 4 D 0 683 D 2022-04-02 Common Stock 683 0 D Stock Option (Right to Buy) 59.28 2015-05-26 4 D 0 208 D 2022-07-02 Common Stock 208 0 D Stock Option (Right to Buy) 65.56 2015-05-26 4 D 0 267 D 2022-10-01 Common Stock 267 0 D Stock Option (Right to Buy) 49.00 2015-05-26 4 D 0 7500 D 2022-11-09 Common Stock 7500 0 D Stock Option (Right to Buy) 61.44 2015-05-26 4 D 0 322 D 2023-01-02 Common Stock 322 0 D Stock Option (Right to Buy) 79.67 2015-05-26 4 D 0 325 D 2023-04-01 Common Stock 325 0 D Stock Option (Right to Buy) 74.48 2015-05-26 4 D 0 3750 D 2023-05-09 Common Stock 3750 0 D Stock Option (Right to Buy) 85.39 2015-05-26 4 D 0 304 D 2023-07-01 Common Stock 304 0 D Stock Option (Right to Buy) 139.89 2015-05-26 4 D 0 184 D 2023-10-01 Common Stock 184 0 D Stock Option (Right to Buy) 108.44 2015-05-26 4 D 0 238 D 2024-01-02 Common Stock 238 0 D Stock Option (Right to Buy) 107.42 2015-05-26 4 D 0 157 D 2024-04-01 Common Stock 157 0 D Stock Option (Right to Buy) 95.08 2015-05-26 4 D 0 3750 D 2024-05-09 Common Stock 3750 0 D Stock Option (Right to Buy) 89.58 2015-05-26 4 D 0 407 D 2024-07-01 Common Stock 407 0 D Stock Option (Right to Buy) 115.80 2015-05-26 4 D 0 314 D 2024-10-01 Common Stock 314 0 D Stock Option (Right to Buy) 124.46 2015-05-26 4 D 0 222 D 2025-01-02 Common Stock 222 0 D Stock Option (Right to Buy) 257.015 2015-05-26 4 D 0 146 D 2025-04-07 Common Stock 146 0 D Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement. /s/ Minesh Mehta 2015-05-27